- Home
- FRGT vs ATXI Comparison
FRGT vs ATXI Comparison
Compare FRGT & ATXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRGT
- ATXI
- Stock Information
- Founded
- FRGT 2015
- ATXI 2015
- Country
- FRGT United States
- ATXI United States
- Employees
- FRGT N/A
- ATXI N/A
- Industry
- FRGT Professional Services
- ATXI Biotechnology: Pharmaceutical Preparations
- Sector
- FRGT Consumer Discretionary
- ATXI Health Care
- Exchange
- FRGT Nasdaq
- ATXI Nasdaq
- Market Cap
- FRGT 2.9M
- ATXI 3.0M
- IPO Year
- FRGT N/A
- ATXI 2017
- Fundamental
- Price
- FRGT $1.36
- ATXI $1.85
- Analyst Decision
- FRGT
- ATXI
- Analyst Count
- FRGT 0
- ATXI 0
- Target Price
- FRGT N/A
- ATXI N/A
- AVG Volume (30 Days)
- FRGT 204.8K
- ATXI 61.4K
- Earning Date
- FRGT 01-28-2025
- ATXI 11-14-2024
- Dividend Yield
- FRGT N/A
- ATXI N/A
- EPS Growth
- FRGT N/A
- ATXI N/A
- EPS
- FRGT N/A
- ATXI N/A
- Revenue
- FRGT $17,567,033.00
- ATXI N/A
- Revenue This Year
- FRGT $144.53
- ATXI N/A
- Revenue Next Year
- FRGT $55.01
- ATXI N/A
- P/E Ratio
- FRGT N/A
- ATXI N/A
- Revenue Growth
- FRGT N/A
- ATXI N/A
- 52 Week Low
- FRGT $1.25
- ATXI $1.60
- 52 Week High
- FRGT $80.75
- ATXI $15.00
- Technical
- Relative Strength Index (RSI)
- FRGT 38.55
- ATXI 47.67
- Support Level
- FRGT $1.25
- ATXI $1.72
- Resistance Level
- FRGT $1.47
- ATXI $2.04
- Average True Range (ATR)
- FRGT 0.20
- ATXI 0.19
- MACD
- FRGT -0.07
- ATXI -0.00
- Stochastic Oscillator
- FRGT 10.09
- ATXI 33.39
About FRGT Freight Technologies Inc.
Freight Technologies Inc is a technology company developing solutions to optimize and automate the supply chain process. Along with its subsidiary, Freight App, Inc, the group is focused on making shipping transparent and efficient. Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity for the once-complex process of international over-the-road (OTR) shipping. The company uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via technologies such as live pricing and real-time tracking, digital freight marketplace, broker, transportation management, fleet management, and committed capacity solutions.
About ATXI Avenue Therapeutics Inc.
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.